Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Free Cash Flow (2016 - 2026)

Rockwell Medical filings provide 16 years of Free Cash Flow readings, the most recent being $2.3 million for Q4 2025.

  • On a quarterly basis, Free Cash Flow rose 379.79% to $2.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.2 million, a 137.64% decrease, with the full-year FY2025 number at -$1.2 million, down 137.64% from a year prior.
  • Free Cash Flow hit $2.3 million in Q4 2025 for Rockwell Medical, up from -$1.6 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $4.1 million in Q3 2024 to a low of -$12.5 million in Q1 2021.
  • Median Free Cash Flow over the past 5 years was -$2.2 million (2023), compared with a mean of -$2.9 million.
  • Biggest five-year swings in Free Cash Flow: tumbled 268.79% in 2023 and later surged 646.51% in 2024.
  • Rockwell Medical's Free Cash Flow stood at -$9.1 million in 2021, then skyrocketed by 95.7% to -$393000.0 in 2022, then soared by 78.12% to -$86000.0 in 2023, then surged by 646.51% to $470000.0 in 2024, then soared by 379.79% to $2.3 million in 2025.
  • The last three reported values for Free Cash Flow were $2.3 million (Q4 2025), -$1.6 million (Q3 2025), and $1.7 million (Q2 2025) per Business Quant data.